The cash flow of BIOGEN INC. over the past 10 years
Chart BIOGEN INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, BIOGEN INC.'s operating cash flow was $2.2B and its capital expenditures $153.8M, leaving free cash flow of $2.05B. Free cash flow was above zero in all 10 years shown. It ranged from $1.14B in fiscal 2022 to $6.26B in fiscal 2019. Capital expenditures were highest in fiscal 2018, at $2.27B.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $2.2B | $153.8M | $2.05B |
| 2024ended Dec 31, 2024 | $2.88B | $153.7M | $2.72B |
| 2023ended Dec 31, 2023 | $1.55B | $277M | $1.27B |
| 2022ended Dec 31, 2022 | $1.38B | $240.3M | $1.14B |
| 2021ended Dec 31, 2021 | $3.64B | $258.1M | $3.38B |
| 2020ended Dec 31, 2020 | $4.23B | $424.8M | $3.81B |
| 2019ended Dec 31, 2019 | $7.08B | $814.5M* | $6.26B |
| 2018ended Dec 31, 2018 | $6.19B | $2.27B* | $3.92B |
| 2017ended Dec 31, 2017 | $4.55B | $2.07B* | $2.48B |
| 2016ended Dec 31, 2016 | $4.59B | $1.82B* | $2.77B |
Fiscal years as BIOGEN INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on BIOGEN INC.
- The revenue of BIOGEN INC.
- The profitability of BIOGEN INC.
- The debt of BIOGEN INC.
- All of BIOGEN INC.'s financials, charted
Companies of a similar size
- CCICROWN CASTLE INC.
- VGVENTURE GLOBAL, INC.
- KVUEKenvue Inc.
- RMDResMed Inc.
- HIGThe Hartford Insurance Group, Inc.
Not investment advice. This page shows what BIOGEN INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.